ArticleJournal of arrhythmia2026
Acute Pericardial Effusion After Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation.
Article in Journal of arrhythmia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vein of Marshall ethanol infusion (VOM-EI) is associated with a higher incidence of pericardial effusion (PE). However, few studies have provided detailed explorations of acute PE following VOM-EI. This study aims to identify the risk factors for acute PE following VOM-EI in patients with persistent atrial fibrillation (PeAF). Methods and Results: We conducted a retrospective analysis of 87 patients who underwent VOM-EI and catheter ablation. All patients underwent PE screening with ultrasound within 12 h post-procedure. Left atrial high-density bipolar voltage mapping was performed before and after VOM-EI to identify the VOM-EI related low-voltage area (LVA). The Boruta algorithm and logistic regression were employed to identify risk factors for PE. The model's performance was assessed using the area under the receiver operating characteristic curve (AUC). Acute post-procedural PE was observed in 22 out of 87 patients (25.2%); no cases of cardiac tamponade occurred. The mean effusion depth was 4.59 ± 2.72 mm. The Boruta algorithm ranked the importance of variables as follows: LVA, procedure time, and heart failure. Multiple logistic regression analysis identified LVA as an independent predictor for PE (OR: 1.15; 95% CI: 1.01-1.30; Conclusions: Acute PE is a common finding after combined VOM-EI and catheter ablation for PeAF. The VOM-EI-related LVA was identified as an independent risk factor for PE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.